<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1212" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1212/" /><meta name="ncbi_pagename" content="Berardinelli-Seip Congenital Lipodystrophy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Berardinelli-Seip Congenital Lipodystrophy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Berardinelli-Seip Congenital Lipodystrophy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/12/08" /><meta name="citation_author" content="Lionel Van Maldergem" /><meta name="citation_pmid" content="20301391" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1212/" /><meta name="citation_keywords" content="Berardinelli-Seip Congenital Generalized Lipodystrophy" /><meta name="citation_keywords" content="Berardinelli-Seip Congenital Generalized Lipodystrophy" /><meta name="citation_keywords" content="1-acyl-sn-glycerol-3-phosphate acyltransferase beta" /><meta name="citation_keywords" content="Seipin" /><meta name="citation_keywords" content="AGPAT2" /><meta name="citation_keywords" content="BSCL2" /><meta name="citation_keywords" content="Berardinelli-Seip Congenital Lipodystrophy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Berardinelli-Seip Congenital Lipodystrophy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lionel Van Maldergem" /><meta name="DC.Date" content="2016/12/08" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1212/" /><meta name="description" content="Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality." /><meta name="og:title" content="Berardinelli-Seip Congenital Lipodystrophy" /><meta name="og:type" content="book" /><meta name="og:description" content="Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1212/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/bscl/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1212/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88451CDFC83B2100000000043E01F7.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1212_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1212_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bws/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bvd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1212_"><span class="title" itemprop="name">Berardinelli-Seip Congenital Lipodystrophy</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Berardinelli-Seip Congenital Generalized Lipodystrophy</div><p class="contrib-group"><span itemprop="author">Lionel Van Maldergem</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1212_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1212_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lionel Van Maldergem</span>, MD, PhD<div class="affiliation small">Centre de G&#x000e9;n&#x000e9;tique Humaine<br />Universit&#x000e9; de Franche-Comt&#x000e9;<br />Besan&#x000e7;on, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.orpyks@dlamv" class="oemail">eb.orpyks@dlamv</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 8, 2003</span>; Last Update: <span itemprop="dateModified">December 8, 2016</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="bscl.Summary" itemprop="description"><h2 id="_bscl_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Berardinelli-Seip <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of BSCL is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with three <a href="#bscl.Major_Criteria">major criteria</a> or two major criteria plus two or more <a href="#bscl.Minor_Criteria">minor criteria</a> and/or by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>AGPAT2</i> or <i>BSCL2</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Restriction of total fat intake between 20% and 30% of total dietary energy maintains normal triglyceride serum concentration. Leptin therapy for treatment of hypertriglyceridemia and diabetes may be considered. Diabetes mellitus is managed as in childhood-onset diabetes mellitus.</p><p><i>Surveillance</i>: Regular screening for glycosuria as a manifestation of diabetes mellitus, which usually starts in the teens (average age 12 years) but has also been described in infancy; monitoring for potential retinal, peripheral nerve, and renal complications of diabetes mellitus; yearly echocardiogram; yearly or biennial liver ultrasound examination to detect fatty infiltration.</p><p><i>Agents/circumstances to avoid:</i> Excessive dietary fat intake.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>BSCL is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="bscl.Diagnosis"><h2 id="_bscl_Diagnosis_">Diagnosis</h2><div id="bscl.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Berardinelli-Seip <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lipodystrophy (BSCL) <b>should be suspected</b> in individuals with one or more of the following major and/or minor findings.</p><div id="bscl.Major_Criteria"><h4>Major Criteria</h4><p><b>Lipoatrophy affecting the trunk, limbs, and face.</b> Generalized lipodystrophy is apparent at birth. In some individuals, the face may be normal at birth with lipoatrophy becoming apparent during the first months of life. Lipoatrophy gives an athletic appearance, especially because skeletal muscle hypertrophy is also present.</p><p><b>Acromegaloid features</b> include gigantism, muscular hypertrophy, advanced bone age, prognathism, prominent orbital ridges, enlarged hands and feet, clitoromegaly, and enlarged external genitalia in males.</p><p><b>Hepatomegaly.</b> Liver enlargement is secondary to fatty liver early on and to cirrhosis late in the disease course.</p><p><b>Elevated serum concentration of triglycerides.</b> Serum concentration of triglycerides can be elevated up to 80 g/L, and is sometimes associated with hypercholesterolemia.</p><p><b>Insulin resistance.</b> Elevated serum concentrations of insulin and C-peptide may occur starting in the first years of life. Its early clinical expression is acanthosis nigricans of the groin, neck, and axillae, which may have, in some cases, a verrucous appearance.</p></div><div id="bscl.Minor_Criteria"><h4>Minor Criteria</h4><p><b>Hypertrophic cardiomyopathy</b> may be present in infancy or develop later in life.</p><p><b>Psychomotor retardation or mild (IQ 50-70) to moderate (IQ 35-50) intellectual impairment.</b> See <a href="#bscl.Phenotype_Correlations_by_Gene">Phenotype Correlations by Gene</a>.</p><p><b>Hirsutism</b> manifests with low frontal and posterior hairline; hypertrichosis is apparently independent of hormonal stimulation.</p><p><b>Precocious puberty in females.</b> In a series of 75 individuals with BSCL, three females underwent puberty before age seven years [<a class="bk_pop" href="#bscl.REF.van_maldergem.2002.722">Van Maldergem et al 2002</a>].</p><p><b>Bone cysts</b> occur in 8%-20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and have a polycystic appearance on x-ray. Located in the epiphyseal and metaphyseal regions of the long bones, bone cysts are often diagnosed during the second decade and are mostly observed in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>AGPAT2</i>.</p><p><b>Phlebomegaly.</b> Prominence of the veins of the lower and upper limbs is observed, in part because of the lack of subcutaneous fat.</p></div></div><div id="bscl.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of BSCL <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with three <a href="#bscl.Major_Criteria">major criteria</a> or two major criteria plus two or more <a href="#bscl.Minor_Criteria">minor criteria</a>
<b>and/or</b> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the genes listed in <a class="figpopup" href="/books/NBK1212/table/bscl.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figbsclTmoleculargenetictestingusedin" rid-ob="figobbsclTmoleculargenetictestingusedin">Table 1</a>.</p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b></p><ul><li class="half_rhythm"><div>In individuals with intellectual disability or cardiomyopathy, sequencing of <i>BSCL2</i> should be considered first.</div></li><li class="half_rhythm"><div>The order of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> may also be stratified by the ethnicity of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual (see <a class="figpopup" href="/books/NBK1212/table/bscl.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figbsclTmoleculargenetictestingusedin" rid-ob="figobbsclTmoleculargenetictestingusedin">Table 1</a>, footnotes 5, 6, 8 and 9).</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>AGPAT2</i> and <i>BSCL2</i> and other genes of interest (see <a href="#bscl.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>AGPAT2</i> and <i>BSCL2</i>) fails to confirm a diagnosis in an individual with features of BSCL. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="bscl.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Berardinelli-Seip Congenital Lipodystrophy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1212/table/bscl.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bscl.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of BSCL Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Test Method</th></tr><tr><th headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></th><th headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AGPAT2</i></td><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 5</td><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 6</td><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BSCL2</i></td><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 8</td><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 9</td><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 10</td></tr><tr><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_bscl.T.molecular_genetic_testing_used_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bscl.TF.1.1"><p class="no_margin">See <a href="/books/NBK1212/#bscl.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="bscl.TF.1.2"><p class="no_margin">See <a href="#bscl.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="bscl.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="bscl.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="bscl.TF.1.5"><p class="no_margin"><i>AGPAT2</i> pathogenic variants accounted for the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (26/45) in a study from the US [<a class="bk_pop" href="#bscl.REF.agarwal.2003.4840">Agarwal et al 2003</a>]. Individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>AGPAT2</i> have been described worldwide, with clusters in sub-Saharan Africa, Brazil, Maghreb (Morocco, Algeria, and Tunisia) and occasionally Middle Eastern countries (e.g., Turkey) and northern Europe [<a class="bk_pop" href="#bscl.REF.van_maldergem.2002.722">Van Maldergem et al 2002</a>].</p></div></dd><dt>6. </dt><dd><div id="bscl.TF.1.6"><p class="no_margin">Nearly all individuals of African origin with BSCL have the <i>AGPAT2</i>
<a class="figpopup" href="/books/NBK1212/table/bscl.T.selected_agpat2_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figbsclTselectedagpat2pathogenicvarian" rid-ob="figobbsclTselectedagpat2pathogenicvarian">c.589-2A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Other pathogenic variants have now been described worldwide in diverse populations.</p></div></dd><dt>7. </dt><dd><div id="bscl.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>8. </dt><dd><div id="bscl.TF.1.8"><p class="no_margin">Pathogenic variants in <i>BSCL2</i> account for the majority of cases in the Berardinelli-Seip study group [<a class="bk_pop" href="#bscl.REF.van_maldergem.2002.722">Van Maldergem et al 2002</a>, <a class="bk_pop" href="#bscl.REF.magr_.2003.1573">Magr&#x000e9; et al 2003</a>] in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals originated mostly from Europe, the Middle East, and sub-Saharan Africa; studies from Brazil draw similar conclusions (18/26) [<a class="bk_pop" href="#bscl.REF.fu.2004.2916">Fu et al 2004</a>, <a class="bk_pop" href="#bscl.REF.miranda.2009.512">Miranda et al 2009</a>]; likewise, in a small sample from Japan, three of four affected individuals were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a <i>BSCL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#bscl.REF.ebihara.2004.2360">Ebihara et al 2004</a>].</p></div></dd><dt>9. </dt><dd><div id="bscl.TF.1.9"><p class="no_margin"><i>BSCL2</i> <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a> <a class="figpopup" href="/books/NBK1212/table/bscl.T.selected_bscl2_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figbsclTselectedbscl2pathogenicvariant" rid-ob="figobbsclTselectedbscl2pathogenicvariant">c.317_321delATCGT</a> is identified in the Lebanese population [<a class="bk_pop" href="#bscl.REF.magr_.2001.365">Magr&#x000e9; et al 2001</a>]. Other pathogenic variants are identified in individuals of European, Middle Eastern, Asian, or Portuguese ancestry.</p></div></dd><dt>10. </dt><dd><div id="bscl.TF.1.10"><p class="no_margin">One large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> and one large <a class="def" href="/books/n/gene/glossary/def-item/indel/">indel</a> have been reported [<a class="bk_pop" href="#bscl.REF.magr_.2001.365">Magr&#x000e9; et al 2001</a>].</p></div></dd><dt>11. </dt><dd><div id="bscl.TF.1.11"><p class="no_margin"><a class="bk_pop" href="#bscl.REF.magr_.2003.1573">Magr&#x000e9; et al [2003]</a> found that 92/94 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals harbor pathogenic variants that are either in <i>BSCL2</i> or <i>AGPAT2</i> or appear to be linked to their loci; <a class="bk_pop" href="#bscl.REF.agarwal.2004.336">Agarwal et al [2004]</a> found this to be the case in 44/47 affected persons. Other reports provide evidence for at least two additional loci associated with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> generalized lipodystrophy and other findings, resulting from <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CAV1</i> or <i>CAVIN1</i> (formerly <i>PTRF</i>) respectively (see <a href="#bscl.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#bscl.REF.kim.2008.1129">Kim et al 2008</a>, <a class="bk_pop" href="#bscl.REF.simha.2008.2318">Simha et al 2008</a>, <a class="bk_pop" href="#bscl.REF.hayashi.2009.2623">Hayashi et al 2009</a>, <a class="bk_pop" href="#bscl.REF.shastry.2010.2245">Shastry et al 2010</a>].</p></div></dd></dl></div></div></div></div></div><div id="bscl.Clinical_Characteristics"><h2 id="_bscl_Clinical_Characteristics_">Clinical Characteristics</h2><div id="bscl.Clinical_Description"><h3>Clinical Description</h3><p>Berardinelli-Seip <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lipodystrophy (BSCL) is mostly diagnosed at birth or soon thereafter. Severe forms of BSCL may have prenatal onset with intrauterine growth retardation. Presentation in the first months of life includes failure to thrive (or conversely gigantism), hepatomegaly, lipoatrophy, facial dysmorphia, enlarged tongue, or developmental delay. All children with the neonatal or infantile presentation demonstrate lipoatrophy in the first year of life.</p><p>Affected adults may first be seen in the plastic surgery clinic seeking cosmetic improvement of facial lipoatrophy or in the cardiology clinic or gastroenterology clinic for manifestations such as hypertrophic cardiomyopathy or hepatomegaly.</p><p><b>Endocrinologic findings</b></p><ul><li class="half_rhythm"><div>Affected individuals develop insulin resistance and approximately 25%-35% of individuals develop diabetes mellitus, most commonly between the ages 15 and 20 years. Diabetes mellitus:</div><ul><li class="half_rhythm"><div>Can be difficult to control;</div></li><li class="half_rhythm"><div>Manifests by weight loss, polydipsia, polyuria, or asthenia and is frequently the presenting finding in the second decade;</div></li><li class="half_rhythm"><div>Presents on occasion in early adulthood.</div></li></ul></li><li class="half_rhythm"><div>Some women present with oligomenorrhea, amenorrhea, or features of polycystic ovary syndrome.</div></li></ul><p><b>Hypertrophic cardiomyopathy</b> is reported in 20%-25% of individuals and is a significant cause of morbidity from cardiac failure and early mortality around age 30 years.</p><ul><li class="half_rhythm"><div>Three children of Pakistani, Chinese, and Turkish ancestry, respectively, came to medical attention in the first year of life with cardiac failure associated with hypertrophic cardiomyopathy [<a class="bk_pop" href="#bscl.REF.friguls.2009.14">Friguls et al 2009</a>, <a class="bk_pop" href="#bscl.REF.jeninga.2012.47">Jeninga et al 2012</a>, <a class="bk_pop" href="#bscl.REF.debray.2013.227">Debray et al 2013</a>].</div></li><li class="half_rhythm"><div>Affected individuals have died as early as age 19 months of complications of cardiomyopathy.</div></li></ul><p><b>Hepatic findings.</b> Because of the absence of functional adipocytes, lipid is stored in other tissues including liver. Hepatomegaly secondary to hepatic steatosis occurs in virtually all individuals with BSCL.</p><p><b>Intellectual impairment</b> is common; <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>, including variability in intellectual impairment, exists.</p><p><b>Skeletal muscle</b> hypertrophy occurs in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals as a result of lipid storage in skeletal muscle.</p></div><div id="bscl.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p><b><i>BSCL2.</i></b> Approximately 80% of individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>BSCL2</i> have mild-to-moderate intellectual impairment, whereas only 10% of individuals with biallelic pathogenic variants in <i>AGPAT2</i> have intellectual impairment.</p></div><div id="bscl.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b><i>AGPAT2.</i></b> No relationship appears to exist between the site and type of <i>AGPAT2</i> pathogenic variants and severity of lipodystrophy or metabolic complications.</p><p><b><i>BSCL2.</i></b> With one exception (see following), no correlation between the site and type of a <i>BSCL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (including intellectual impairment) has been observed [<a class="bk_pop" href="#bscl.REF.van_maldergem.2002.722">Van Maldergem et al 2002</a>]. Furthermore, related and unrelated individuals with the same pathogenic variant may be discordant for intellectual impairment.</p><p>A severe form of BSCL characterized by lipodystrophy followed after a couple of months by neurologic regression and death has been described in five infants in Spain [<a class="bk_pop" href="#bscl.REF.guill_nnavarro.2013.401">Guill&#x000e9;n-Navarro et al 2013</a>]. Affected infants were either <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <i>BSCL2</i> pathogenic <a class="figpopup" href="/books/NBK1212/table/bscl.T.selected_bscl2_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figbsclTselectedbscl2pathogenicvariant" rid-ob="figobbsclTselectedbscl2pathogenicvariant">c.793C&#x0003e;T</a> variant or had this <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in combination with another pathogenic variant on the other <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. The pathogenic c.793C&#x0003e;T variant causes <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7 skipping.</p></div><div id="bscl.Nomenclature"><h3>Nomenclature</h3><p>Berardinelli-Seip syndrome is named after W Berardinelli, who reported the first <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from Brazil in 1954. The syndrome was confirmed in 1959 in Norway by Martin Seip, whose affected population originated from the county of Rogaland. In the European literature, the terms "Seip syndrome," "generalized lipodystrophy," "<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> generalized lipodystrophy," or "total lipodystrophy" have been used.</p><p>Brunzell syndrome is the association of bone cysts and lipoatrophic diabetes mellitus described in five <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> African Americans from the same sibship. Originally Brunzell syndrome was thought to be a separate entity, but it is now generally recognized that bone cysts represent a rare complication of Berardinelli-Seip <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lipodystrophy. Furthermore, <a class="bk_pop" href="#bscl.REF.fu.2004.2916">Fu et al [2004]</a> identified <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>AGPAT2</i> in three sibs with Brunzell syndrome.</p><p>After onset of diabetes mellitus, some have termed individuals with BSCL as having "lipoatrophic diabetes."</p><p>Lawrence syndrome is synonymous with acquired generalized lipodystrophy [<a class="bk_pop" href="#bscl.REF.garg.2011.3313">Garg 2011</a>].</p></div><div id="bscl.Prevalence"><h3>Prevalence</h3><p>More than three hundred cases of BSCL have been reported in the medical literature. Prevalence estimates:</p><ul><li class="half_rhythm"><div>USA: 1:10,000,000 [<a class="bk_pop" href="#bscl.REF.agarwal.2006.175">Agarwal &#x00026; Garg 2006</a>]</div></li><li class="half_rhythm"><div>Norway: 1:1,000,000</div></li><li class="half_rhythm"><div>Lebanon: 1:200,000</div></li><li class="half_rhythm"><div>Portugal: 1:500,000</div></li><li class="half_rhythm"><div>Sultanate of Oman: 1:25,000 [<a class="bk_pop" href="#bscl.REF.rajab.2005.27">Rajab et al 2005</a>]</div></li></ul></div></div><div id="bscl.Genetically_Related_Allelic_Disorde"><h2 id="_bscl_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p><b><i>AGPAT2.</i></b> No other phenotypes are associated with pathogenic variants in <i>AGPAT2</i>, assuming that Brunzell syndrome is classic BSCL with one of its late complications, bone cysts.</p><p><b><i>BSCL2.</i></b> Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <i>BSCL2</i> have been identified in <a href="/books/n/gene/spg17/"><i>BSCL2</i>-related neurologic disorders</a>, a spectrum of conditions that includes: Charcot-Marie-Tooth disease type 2 (see <a href="/books/n/gene/cmt/">CMT Overview</a>), distal hereditary motor neuropathy type V, spastic paraplegia 17, and Silver syndrome [<a class="bk_pop" href="#bscl.REF.windpassinger.2004.271">Windpassinger et al 2004</a>]. The clinical features of these <i>BSCL2</i>-related neurologic disorders include:</p><ul><li class="half_rhythm"><div>Onset of symptoms ranging from the first to the seventh decade (6-66 years; mean: 19 years)</div></li><li class="half_rhythm"><div>Slow disease progression</div></li><li class="half_rhythm"><div>Upper-motor neuron involvement: gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses</div></li><li class="half_rhythm"><div>Lower motor neuron involvement: amyotrophy (wasting) of the peroneal muscles and the small muscles of the hand (particularly the thenar and interosseus dorsalis I muscles) that is frequently unilateral</div></li><li class="half_rhythm"><div>Usually normal sensation except for pallesthesia (i.e., abnormal vibration sense)</div></li><li class="half_rhythm"><div>Pes cavus and other foot deformities</div></li><li class="half_rhythm"><div>Autosomal dominant inheritance</div></li></ul></div><div id="bscl.Differential_Diagnosis"><h2 id="_bscl_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Congenital generalized lipodystrophy 3 (CGL3)</b> (OMIM <a href="http://omim.org/entry/612526" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612526</a>). Individuals with this condition typically have serum creatine kinase concentrations between 2.5 and ten times the upper limit of normal in addition to features resembling classic BSCL [<a class="bk_pop" href="#bscl.REF.kim.2008.1129">Kim et al 2008</a>]. Two sibs of Hispanic ancestry with a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <i>CAV1</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant and hypotonia, elevated serum creatine kinase, atlas-axis instability, and generalized lipodystrophy have been described [<a class="bk_pop" href="#bscl.REF.simha.2008.2318">Simha et al 2008</a>].</p><p><b>Congenital generalized lipodystrophy 4 (CGL4)</b> (OMIM <a href="http://omim.org/entry/613327" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613327</a>). Generalized lipodystrophy, distal myopathy, muscular hypertrophy, hypertriglyceridemia, insulin resistance, elevated serum creatine kinase concentration, and normal intelligence were described in five Japanese individuals with pathogenic variants in <i>CAVIN1</i> (formerly <i>PTRF</i>), encoding polymerase I and transcript release factor [<a class="bk_pop" href="#bscl.REF.hayashi.2009.2623">Hayashi et al 2009</a>]. A series of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with cardiac arrhythmia originating from Oman and the UK were reported by <a class="bk_pop" href="#bscl.REF.rajab.2010.e1000874">Rajab et al [2010]</a>. The polymerase I and transcript release factor protein is thought to play an essential role in the formation of caveolae (invaginations of the plasma membrane involved in many cellular processes, including clathrin-independent endocytosis, cholesterol transport, and signal transduction) and the stabilization of caveolins, proteins present in the caveolae. These data confirm caveolin deficiency as a cause of the lipodystrophic process.</p><p><b>Further diagnoses to consider</b> include the following:</p><p><b>In infancy</b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/short/">SHORT syndrome</a></div></li><li class="half_rhythm"><div>Neonatal progeroid syndrome (OMIM <a href="http://omim.org/entry/264090" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">264090</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/marfan/">Marfan syndrome</a>, progeroid subtype, caused by pathogenic variants at the C-terminus of <i>FBN1</i> [<a class="bk_pop" href="#bscl.REF.graulneumann.2010.2749">Graul-Neumann et al 2010</a>]</div></li><li class="half_rhythm"><div>Neurometabolic lysosomal storage disorders: <a href="/books/n/gene/gaucher/">Gaucher disease type 2</a>, <a href="/books/n/gene/krabbe/">Krabbe disease</a></div></li><li class="half_rhythm"><div>Russell diencephalic syndrome</div></li><li class="half_rhythm"><div>Leprechaunism: Donohue syndrome (see <a href="/books/n/gene/insr-ir/">INSR-Related Severe Syndromic Insulin Resistance</a>)</div></li></ul><p><b>In childhood</b></p><ul><li class="half_rhythm"><div>Familial partial Dunnigan-Ko&#x000eb;berling lipodystrophy (OMIM <a href="http://omim.org/entry/151660" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">151660</a>)</div></li><li class="half_rhythm"><div>Rabson-Mendenhall syndrome (see <a href="/books/n/gene/insr-ir/">INSR-Related Severe Syndromic Insulin Resistance</a>)</div></li><li class="half_rhythm"><div>Insulin-dependent diabetes mellitus</div></li><li class="half_rhythm"><div>Acquired generalized lipodystrophy (Lawrence syndrome) [<a class="bk_pop" href="#bscl.REF.misra.2003.129">Misra &#x00026; Garg 2003</a>]. Three subtypes exist.</div></li><li class="half_rhythm"><div>Mandibuloacral dysplasia (MAD) caused by <i>LMNA/C</i> and <i>ZMPSTE24</i> pathogenic variants (see <a href="http://omim.org/phenotypicSeries/PS248370" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mandibuloacral dysplasia with lipodystrophy: OMIM Phenotypic Series</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hgps/">Hutchinson-Gilford progeria syndrome</a></div></li></ul><p><b>In adulthood</b></p><ul><li class="half_rhythm"><div>Acquired partial lipodystrophy (Barraquer-Simons syndrome) (OMIM <a href="http://omim.org/entry/608709" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608709</a>)</div></li><li class="half_rhythm"><div>Lipodystrophy associated with human immunodeficiency virus infection</div></li><li class="half_rhythm"><div>Partial lipodystrophy with C3 nephritic factor (OMIM <a href="http://omim.org/entry/613913" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613913</a>)</div></li><li class="half_rhythm"><div>Acquired generalized lipodystrophy (Lawrence syndrome)</div></li></ul><p>See <a href="http://omim.org/phenotypicSeries/PS608594" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lipodystrophy, congenital generalized: OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div><div id="bscl.Management"><h2 id="_bscl_Management_">Management</h2><div id="bscl.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Berardinelli-Seip <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lipodystrophy (BSCL), the following clinical evaluations are recommended:</p><ul><li class="half_rhythm"><div>Complete blood count</div></li><li class="half_rhythm"><div>Serum concentration of electrolytes, AST, alanine transaminase, urea, creatinine, insulin, C-peptide, triglycerides, and cholesterol</div></li><li class="half_rhythm"><div>Oral glucose tolerance test; when appropriate, clamp glucose homeostasis study</div></li><li class="half_rhythm"><div>Ultrasound of the liver to evaluate liver size and fatty content</div></li><li class="half_rhythm"><div>Echocardiogram to evaluate for cardiac hypertrophy</div></li><li class="half_rhythm"><div>Renal ultrasound examination to evaluate for kidney size</div></li><li class="half_rhythm"><div>Physical examination for orthopedic complications including reduced hip mobility and genu valgum</div></li><li class="half_rhythm"><div>Skeletal survey, especially of the long bones, to evaluate for bone cysts</div></li><li class="half_rhythm"><div>Bone age and assessment of sexual maturity rating/pubertal status</div></li><li class="half_rhythm"><div>Complete ophthalmologic examination, including slit lamp examination, to evaluate for ophthalmologic complications due to hyperlipemia and/or diabetes mellitus</div></li><li class="half_rhythm"><div>Assessment of cognitive ability with age-appropriate scales</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="bscl.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Restriction of total fat intake between 20% and 30% of total dietary energy is often sufficient to maintain normal triglyceride serum concentration.</p><p>Fibric acid derivatives and n-3 polyunsaturated fatty acids derived from fish oils can be tried for the treatment of extreme hypertriglyceridemia.</p><p>Leptin treatment has proven successful in controlling both hypertriglyceridemia and diabetes mellitus [<a class="bk_pop" href="#bscl.REF.garg.1999.3390">Garg et al 1999</a>, <a class="bk_pop" href="#bscl.REF.beltrand.2007.e291">Beltrand et al 2007</a>, <a class="bk_pop" href="#bscl.REF.ebihara.2007.532">Ebihara et al 2007</a>]. Despite the absence of well-controlled randomized studies that could provide a more thorough assessment of the possible adverse effects of leptin therapy, the United States Food and Drug Administration granted approval of leptin administration [<a class="bk_pop" href="#bscl.REF.tsoukas.2015.47">Tsoukas et al 2015</a>].</p><p>Management of diabetes mellitus does not differ from that of childhood-onset diabetes mellitus.</p><p>Special education is required for individuals with psychomotor retardation or intellectual disability.</p></div><div id="bscl.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>Dietary restriction of total fat intake may prevent hypertriglyceridemia (see <a href="#bscl.Treatment_of_Manifestations">Treatment of Manifestations</a>).</p></div><div id="bscl.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div class="half_rhythm">Periodic screening for glycosuria as a manifestation of diabetes mellitus</div></li><li class="half_rhythm"><div class="half_rhythm">For individuals with diabetes mellitus, follow-up in a diabetes clinic every six months to monitor for possible retinal, peripheral nerve, and renal complications</div></li><li class="half_rhythm"><div class="half_rhythm">Yearly cardiac ultrasound and EKG</div></li><li class="half_rhythm"><div class="half_rhythm">Yearly or biennial liver ultrasound examination to detect fatty infiltration</div><div class="half_rhythm">Ultrasound surveillance is a noninvasive procedure that can, along with serum lipid concentrations and liver enzymes, provide information on the degree of lipid control and compliance with the fat-restricted diet.</div></li></ul></div><div id="bscl.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Excessive dietary fat intake should be avoided.</p></div><div id="bscl.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#bscl.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="bscl.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Affected pregnant women should be followed in a high-risk pregnancy care unit by a multidisciplinary team including a specialist in fetal medicine and an expert in diabetic management. Pregnancy may increase the risk of diabetic decompensation. Babies born to women with diabetes are at an increased risk for fetal anomalies and postnatal complications compared to babies born to women without diabetes.</p></div><div id="bscl.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="bscl.Other"><h3>Other</h3><p>Other drugs, including fenfluramine, have no proven efficacy and should be avoided.</p></div></div><div id="bscl.Genetic_Counseling"><h2 id="_bscl_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="bscl.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Berardinelli-Seip <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lipodystrophy (BSCL) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="bscl.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one BSCL-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic; increased incidence of diabetes mellitus has been suggested but never confirmed.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic, although increased incidence of diabetes mellitus is suggested.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with BSCL are obligate heterozygotes (carriers) for a BSCL-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>:</p><ul><li class="half_rhythm"><div>Pregnancies in individuals with BSCL type 1 have been described [<a class="bk_pop" href="#bscl.REF.van_maldergem.2002.722">Van Maldergem et al 2002</a>].</div></li><li class="half_rhythm"><div>Many individuals with BSCL type 2 (BSCL2) do not reproduce.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a BSCL-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="bscl.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the BSCL-related pathogenic variants in the family.</p></div><div id="bscl.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>Differentiation between BSCL type 1 and BSCL type 2 may be useful for purposes of <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>, particularly if the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is too young for cognitive development to have been clearly characterized.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bscl.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the BSCL-related pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for a pregnancy at increased risk for BSCL are possible.</p></div></div><div id="bscl.Resources"><h2 id="_bscl_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/congenital-generalized-lipodystrophy" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Congenital generalized lipodystrophy</a></div></li><li class="half_rhythm"><div><b>American Diabetes Association (ADA)</b></div><div><b>Phone:</b> 1-800-DIABETES (800-342-2383)</div><div><b>Email:</b> AskADA@diabetes.org</div><div><a href="http://www.diabetes.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.diabetes.org</a></div></li><li class="half_rhythm"><div><b>Diabetes UK</b></div><div>United Kingdom</div><div><b>Phone:</b> 0345 123 2399</div><div><b>Fax:</b> 020 7424 1001</div><div><b>Email:</b> info@diabetes.org.uk</div><div><a href="http://www.diabetes.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.diabetes.org.uk</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="bscl.Molecular_Genetics"><h2 id="_bscl_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="bscl.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Berardinelli-Seip Congenital Lipodystrophy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1212/table/bscl.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bscl.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_bscl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_bscl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_bscl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_bscl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_bscl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_bscl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_bscl.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_bscl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">BSCL1</td><td headers="hd_b_bscl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10555" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AGPAT2</i></a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10555" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q34<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15120" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1-acyl-sn-glycerol-3-phosphate acyltransferase beta</a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/AGPAT2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AGPAT2 database</a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AGPAT2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AGPAT2</a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AGPAT2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AGPAT2</a></td></tr><tr><td headers="hd_b_bscl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">BSCL2</td><td headers="hd_b_bscl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/26580" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>BSCL2</i></a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=26580" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q12<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96G97" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Seipin</a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://reseq.biosciencedbc.jp/resequence/GeneDetail.do?targetId=9&#x00026;geneId=EG26580" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HSP mutation database (BSCL2)</a><br /><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=31" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, BSCL2</a><br /><a href="http://databases.lovd.nl/shared/genes/BSCL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BSCL2 database</a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=BSCL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BSCL2</a></td><td headers="hd_b_bscl.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=BSCL2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">BSCL2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="bscl.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="bscl.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Berardinelli-Seip Congenital Lipodystrophy (<a href="/omim/269700,603100,606158,608594" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1212/table/bscl.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bscl.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/269700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">269700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 2; AGPAT2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606158" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606158</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BSCL2 GENE; BSCL2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608594" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608594</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1</td></tr></tbody></table></div></div><div id="bscl.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Pathogenic variants in <i>AGPAT2,</i> encoding AGPAT2, and <i>BSCL2</i>, encoding seipin, cause BSCL. AGPAT2 (1-acyl-sn-glycerol-3-phosphate acyltransferase beta) is a key enzyme in the biosynthesis of triglycerides. Seipin, which is less well understood, is predicted to play a role in the maintenance and formation of lipid-containing vesicles.</p><div id="bscl.AGPAT2"><h4><i>AGPAT2</i></h4><p><b>Gene structure.</b>
<i>AGPAT2</i> consists of six exons spanning less than 20 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1212/#bscl.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Homozygous or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> <i>AGPAT2</i> variants are associated with BSCL. <a class="bk_pop" href="#bscl.REF.agarwal.2002.21">Agarwal et al [2002]</a> identified various <i>AGPAT2</i> variants in 11 pedigrees, including a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> resulting in a <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a> and premature termination codon, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, and single amino-acid deletions. <a class="bk_pop" href="#bscl.REF.magr_.2003.1573">Magr&#x000e9; et al [2003]</a> also reported various pathogenic variants in 38 individuals from 30 pedigrees (for more information, see databases in <a href="/books/NBK1212/#bscl.molgen.TA">Table A</a>).</p><div id="bscl.T.selected_agpat2_pathogenic_varian" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>AGPAT2</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1212/table/bscl.T.selected_agpat2_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bscl.T.selected_agpat2_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.183-2A&#x0003e;G<br />(c.IVS1-2A&#x0003e;G)&#x000a0;<sup>2</sup></td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_3" rowspan="17" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/68835055" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006412<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/6041665" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006403<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.182+1G&#x0003e;A<br />(c.IVS1+1G&#x0003e;A)</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.194G&#x0003e;A</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp65Ter</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.202C&#x0003e;T</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg68Ter</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.299G&#x0003e;A</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser100Asn</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.335C&#x0003e;T</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro112Leu</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.492+1G&#x0003e;A<br />(c.IVS3+1G&#x0003e;A)</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.493-1G&#x0003e;C<br />(c.IVS3-1G&#x0003e;C)&#x000a0;<sup>2</sup></td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">del exon3 &#x02013; <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4<br />(c.del317_588)&#x000a0;<sup>2</sup></td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu107AlafsTer279</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.514G&#x0003e;A</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu172Lys</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.538delG<br />(c.del538G)</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp180ThrfsTer73</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.589-2A&#x0003e;G<br />(c.IVS4-2A&#x0003e;G)&#x000a0;<sup>2</sup></td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.646A&#x0003e;T</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys216Ter</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.661+2T&#x0003e;G<br />(c.IVS5+2T&#x0003e;G)</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.676C&#x0003e;T</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln226Ter</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.713C&#x0003e;G</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala238Gly</td></tr><tr><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.755_763del9<br />(c.del755_764)</td><td headers="hd_h_bscl.T.selected_agpat2_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met252_Thr254del</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="bscl.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="bscl.TF.2.2"><p class="no_margin">Recurrent variant</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The AGPAT2 protein, 1-acyl-sn-glycerol-3-phosphate acyltransferase beta (also known as lysophosphatidic acid acyltransferase beta [LPAAT]), has 278 amino acids and belongs to the family of acyltransferases. The AGPAT2 enzyme catalyzes an essential reaction in the biosynthetic pathway of glycerophospholipids and triacylglycerol [<a class="bk_pop" href="#bscl.REF.agarwal.2002.21">Agarwal et al 2002</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>AGPAT2</i> may cause <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> lipodystrophy by inhibiting/reducing triacylglycerol synthesis and storage in adipocytes. It is also likely that reduced AGPAT2 activity could increase tissue levels of lysophosphatidic acid, which may negatively affect adipocyte functions [<a class="bk_pop" href="#bscl.REF.agarwal.2002.21">Agarwal et al 2002</a>].</p></div><div id="bscl.BSCL2"><h4><i>BSCL2</i></h4><p><b>Gene structure.</b>
<i>BSCL2</i> consists of 11 exons spanning at least 14 kb. The putative translation initiation codon is located in the second <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1212/#bscl.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><i>BSCL2</i> has no significant homology to other known proteins. Multiple seipin transcripts of 1.8, 2.0, and 2.4 kb have been identified by RNA blot analysis. The 1.8- and 2.4-kb transcripts are ubiquitous whereas the 2.0 kb transcript is expressed selectively and at high levels in brain and testis. It has been postulated that this distribution could account for the intellectual disability, voracious appetite, and macrogenitosomia observed in BSCL type 2.</p><p><b>Pathogenic variants.</b> Homozygous or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> <i>BSCL2</i> variants are associated with BSCL. <a class="bk_pop" href="#bscl.REF.magr_.2001.365">Magr&#x000e9; et al [2001]</a> identified several different variants in <i>BSCL2</i> among 44 individuals, including microdeletions, small insertions and deletions, and five nucleotide substitutions. The majority of pathogenic variants resulted in a frameshift or a premature stop codon (for more information, see databases in <a href="/books/NBK1212/#bscl.molgen.TA">Table A</a>).</p><div id="bscl.T.selected_bscl2_pathogenic_variant" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>BSCL2</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1212/table/bscl.T.selected_bscl2_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bscl.T.selected_bscl2_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.142C&#x0003e;T</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu48Phe</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_3" rowspan="15" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/171906560" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032667<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="/protein/40068505" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_116056<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.154_155dupTT<br />(c.500_502insTT)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr53SerfsTer40</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.193delCinsGGA<br />(c.537_538delCinsGGA)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro65ArgfsTer28</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.317_321delATCGT<br />(c.del659_663)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr106CysfsTer6</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.325dupA<br />(c.324_325 insA)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr109AsnfsTer5</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.412C&#x0003e;T&#x000a0;<sup>2</sup></td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg138Ter</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.574-2A&#x0003e;G<br />(c.IVS5-2A&#x0003e;G)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.672-3C&#x0003e;G<br />(c.IVS6-3C&#x0003e;G)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.672-2A&#x0003e;C<br />(c.IVS6-2 A&#x0003e;C)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.672-2A&#x0003e;G<br />(c.IVS6-2A&#x0003e;G)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.671+5G&#x0003e;A<br />(c.IVS6+5G&#x0003e;A)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.634G&#x0003e;C</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala212Pro</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.782dupG<br />(c.1126_1127insG)</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile262HisfsTer12</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.793C&#x0003e;T</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg265Ter</td></tr><tr><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.823C&#x0003e;T</td><td headers="hd_h_bscl.T.selected_bscl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg275Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="bscl.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="bscl.TF.3.2"><p class="no_margin">Recurrent variant</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>BSCL2</i> encodes a 398-amino-acid protein, seipin (isoform 2, <a href="/protein/40068505" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_116056.3</a>). Seipin has at least two hydrophobic amino acid stretches, indicating that it could be a transmembrane protein. The function of seipin is unknown [<a class="bk_pop" href="#bscl.REF.magr_.2001.365">Magr&#x000e9; et al 2001</a>]; however, it is predicted to be a membrane protein mainly located in endoplasmic reticulum (ER) with a luminal loop <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and with both termini facing the cytoplasm [<a class="bk_pop" href="#bscl.REF.cartwright.2012.1042">Cartwright &#x00026; Goodman 2012</a>].</p><p>The seipin protein has a <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> similar to that contained in the sterol element-binding proteins (SREBPs) which have a role in regulation of cholesterol biosynthesis and uptake. Study of yeast seipin indicates that it is located at the junction of ER and lipid droplets called adiposomes. When seipin is absent, irregularly shaped small lipid droplets replace these well-formed adiposomes, suggesting a role for seipin in the formation or maintenance of these lipid-containing vesicles.</p><p>In addition, studies in mouse models indicate that reduction of seipin strongly reduced expression and synthesis of AGPAT2 and DGAT2, suggesting that seipin is located located upstream in the metabolic pathway[<a class="bk_pop" href="#bscl.REF.payne.2008.2055">Payne et al 2008</a>, <a class="bk_pop" href="#bscl.REF.ito.2009.8">Ito &#x00026; Suzuki 2009</a>].</p><p>Seipin also occurs as another isoform. <i>BSCL2</i> also encodes a protein of 462 amino acids (isoform 1, <a href="/protein/NP_001116427.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001116427.1</a>) (vs 398 amino acids reported in the seminal paper); the 398-amino-acid-based numbering is still used in order to avoid inconsistencies linked to re-numbering.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The majority of <i>BSCL2</i> variants are <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants predicted to result in severe disruption of the protein function. Rare <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been studied. One missense variant in seipin, p.Ala212Pro (found in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in Norway), resulted in mislocalization of adiposomes at the junction of nuclear membrane and ER. The p.Arg275Ter missense variant resulted in misshapen lipid droplets in their orthotopic ER localization [<a class="bk_pop" href="#bscl.REF.payne.2008.2055">Payne et al 2008</a>]. More recently, a dual role for seipin &#x02013; both regulation of lipid homeostasis by inhibiting lipid droplets formation in non-adipocytes and promotion of adipogenesis &#x02013; has been postulated [<a class="bk_pop" href="#bscl.REF.wee.2014.583">Wee et al 2014</a>]. This putative adipogenic role of seipin would not give, at first glance, an explanation for the intellectual impairment often observed in individuals with BSCL. An interaction of seipin with neurotransmission could provide the basis of intellectual disability [<a class="bk_pop" href="#bscl.REF.wei.2013.478">Wei et al 2013</a>].</p></div></div></div><div id="bscl.References"><h2 id="_bscl_References_">References</h2><div id="bscl.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.agarwal.2002.21">Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, Garg A. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">31</span>:21–3.</span> [<a href="/pubmed/11967537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11967537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.agarwal.2004.336">Agarwal AK, Barnes RI, Garg A. Genetic basis of congenital generalized lipodystrophy. <span><span class="ref-journal">Int J Obes Relat Metab Disord. </span>2004;<span class="ref-vol">28</span>:336–9.</span> [<a href="/pubmed/14557833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14557833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.agarwal.2006.175">Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation, and death. <span><span class="ref-journal">Annu Rev Genomics Hum Genet. </span>2006;<span class="ref-vol">7</span>:175–99.</span> [<a href="/pubmed/16722806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16722806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.agarwal.2003.4840">Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O'Rahilly S, Zaidi Z, Gurakan F, Arslanian SA, Klar A, Ricker A, White NH, Bindl L, Herbst K, Kennel K, Patel SB, Al-Gazali L, Garg A. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2003;<span class="ref-vol">88</span>:4840–7.</span> [<a href="/pubmed/14557463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14557463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.beltrand.2007.e291">Beltrand J, Beregszaszi M, Chevenne D, Sebag G, De Kerdanet M, Huet F, Polak M, Tubiana-Rufi N, Lacombe D, De Paoli M, Levy-Marchal C. Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy. <span><span class="ref-journal">Pediatrics. </span>2007;<span class="ref-vol">120</span>:e291–6.</span> [<a href="/pubmed/17671040" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17671040</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.cartwright.2012.1042">Cartwright BR, Goodman JM. Seipin: from human disease to molecular mechanism. <span><span class="ref-journal">J Lipid Res. </span>2012;<span class="ref-vol">53</span>:1042–55.</span> [<a href="/pmc/articles/PMC3351812/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3351812</span></a>] [<a href="/pubmed/22474068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22474068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.debray.2013.227">Debray FG, Baguette C, Colinet S, Van Maldergem L, Verellen-Dumoulin C. Early infantile cardiomyopathy and liver disease: a multisystemic disorder caused by congenital lipodystrophy. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">109</span>:227–9.</span> [<a href="/pubmed/23647707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23647707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.ebihara.2007.532">Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, Tanaka T, Chusho H, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, DePaoli AM, Fukushima M, Nakao K. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2007;<span class="ref-vol">92</span>:532–41.</span> [<a href="/pubmed/17118991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17118991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.ebihara.2004.2360">Ebihara K, Kusakabe T, Masuzaki H, Kobayashi N, Tanaka T, Chusho H, Miyanaga F, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, Nakao K. Gene and phenotype analysis of congenital generalized lipodystrophy in Japanese: a novel homozygous nonsense mutation in seipin gene. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2004;<span class="ref-vol">89</span>:2360–4.</span> [<a href="/pubmed/15126564" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15126564</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.friguls.2009.14">Friguls B, Coroleu W, del Alcazar R, Hilbert P, Van Maldergem L, Pintos-Morell G. Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation. <span><span class="ref-journal">Eur J Med Genet. </span>2009;<span class="ref-vol">52</span>:14–6.</span> [<a href="/pubmed/19041432" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19041432</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.fu.2004.2916">Fu M, Kazlauskaite R, Baracho Mde F, Santos MG, Brand&#x000e3;o-Neto J, Villares S, Celi FS, Wajchenberg BL, Shuldiner AR. Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2004;<span class="ref-vol">89</span>:2916–22.</span> [<a href="/pmc/articles/PMC3390418/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3390418</span></a>] [<a href="/pubmed/15181077" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15181077</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.garg.1999.3390">Garg A, Wilson R, Barnes R, Arioglu E, Zaidi Z, Gurakan F, Kocak N, O'Rahilly S, Taylor SI, Patel SB, Bowcock AM. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1999;<span class="ref-vol">84</span>:3390–4.</span> [<a href="/pubmed/10487716" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10487716</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.garg.2011.3313">Garg A. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2011;<span class="ref-vol">96</span>:3313–25.</span> [<a href="/pubmed/21865368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21865368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.graulneumann.2010.2749">Graul-Neumann LM, Kienitz T, Robinson PN, Baasanjav S, Karow B, Gillessen-Kaesbach G, Fahsold R, Schmidt H, Hoffmann K, Passarge E. Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2749–55.</span> [<a href="/pubmed/20979188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20979188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.guill_nnavarro.2013.401">Guill&#x000e9;n-Navarro E, S&#x000e1;nchez-Iglesias S, Domingo-Jim&#x000e9;nez R, Victoria B, Ruiz-Riquelme A, R&#x000e1;bano A, Loidi L, Beiras A, Gonz&#x000e1;lez-M&#x000e9;ndez B, Ramos A, L&#x000f3;pez-Gonz&#x000e1;lez V, Ballesta-Mart&#x000ed;nez MJ, Garrido-Pumar M, Aguiar P, Ruibal A, Requena JR, Ara&#x000fa;jo-Vilar D. A new seipin-associated neurodegenerative syndrome. <span><span class="ref-journal">J Med Genet. </span>2013;<span class="ref-vol">50</span>:401–9.</span> [<a href="/pubmed/23564749" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23564749</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.hayashi.2009.2623">Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, Park Y-E, Nonaka I, Hino-Fukuyo N, Haginoya K, Sugano H, Nishino I. Human PTFR mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. <span><span class="ref-journal">J Clin Invest. </span>2009;<span class="ref-vol">119</span>:2623–33.</span> [<a href="/pmc/articles/PMC2735915/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2735915</span></a>] [<a href="/pubmed/19726876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19726876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.ito.2009.8">Ito D, Suzuki N. Seipinopathy: a novel endoplasmic reticulum stress-associated disease. <span><span class="ref-journal">Brain. </span>2009;<span class="ref-vol">132</span>:8–15.</span> [<a href="/pubmed/18790819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18790819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.jeninga.2012.47">Jeninga EH, de Vroede M, Hamers N, Breur JM, Verhoeven-Duif NM, Berger R, Kalkhoven E. a patient with congenital generalized lipodystrophy due to a novel mutation in BSCL2: indications for secondary mitochondrial dysfunction. <span><span class="ref-journal">JIMD Rep. </span>2012;<span class="ref-vol">4</span>:47–54.</span> [<a href="/pmc/articles/PMC3509903/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3509903</span></a>] [<a href="/pubmed/23430896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.kim.2008.1129">Kim CA, Del&#x000e9;pine M, Boutet E, El Mourabit H, Le Lay S, Meier M, Nemani M, Bridel E, Leite CC, Bertola DR, Semple RK, O'Rahilly S, Dugail I, Capeau J, Lathrop M, Magr&#x000e9; J. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2008;<span class="ref-vol">93</span>:1129–34.</span> [<a href="/pubmed/18211975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18211975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.magr_.2001.365">Magr&#x000e9; J, Del&#x000e9;pine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, Papp J, Meier M, M&#x000e9;garban&#x000e9; A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, Navarro J, Nivelon-Chevalier A, Polak M, Robert JJ, Tric P, Tubiana-Rufi N, Vigouroux C, Weissenbach J, Savasta S, Maassen JA, Trygstad O, Bogalho P, Freitas P, Medina JL, Bonnicci F, Joffe BI, Loyson G, Panz VR, Raal FJ, O'Rahilly S, Stephenson T, Kahn CR, Lathrop M, Capeau J, et al.  Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:365–70.</span> [<a href="/pubmed/11479539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11479539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.magr_.2003.1573">Magr&#x000e9; J, Del&#x000e9;pine M, Van Maldergem L, Robert JJ, Maassen JA, Meier M, Panz VR, Kim CA, Tubiana-Rufi N, Czernichow P, Seemanova E, Buchanan CR, Lacombe D, Vigouroux C, Lascols O, Kahn CR, Capeau J, Lathrop M. Prevalence of mutations in AGPAT2 among human lipodystrophies. <span><span class="ref-journal">Diabetes. </span>2003;<span class="ref-vol">52</span>:1573–8.</span> [<a href="/pubmed/12765973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12765973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.miranda.2009.512">Miranda DM, Wajchenberg BL, Calsolari MR, Aguiar MJ, Silva JM, Ribeiro MG, Fonseca C, Amaral D, Boson WL, Resende BA, De Marco L. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2009;<span class="ref-vol">71</span>:512–7.</span> [<a href="/pubmed/19226263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19226263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.misra.2003.129">Misra A, Garg A. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. <span><span class="ref-journal">Medicine (Baltimore). </span>2003;<span class="ref-vol">82</span>:129–46.</span> [<a href="/pubmed/12640189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12640189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.payne.2008.2055">Payne VA, Grimsey N, Tuthill A, Gray SL, Dalla Nora E, Semple RK, O&#x02019;Rahilly S, Rochford JJ. The human lipodystrophy gene BSCL2/seipin may be essential for adipocyte normal differentiation. <span><span class="ref-journal">Diabetes. </span>2008;<span class="ref-vol">57</span>:2055–60.</span> [<a href="/pmc/articles/PMC2494687/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2494687</span></a>] [<a href="/pubmed/18458148" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18458148</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.rajab.2005.27">Rajab A, Bappal B, Al-Shaikh H, Al-Khusaibi S, Mohammed AJ. Common autosomal recessive diseases in Oman derived from a hospital-based registry. <span><span class="ref-journal">Community Genet. </span>2005;<span class="ref-vol">8</span>:27–30.</span> [<a href="/pubmed/15767751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15767751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.rajab.2010.e1000874">Rajab A, Straub V, McCann LJ, Seelow D, Varon R, Barresi R, Schulze A, Lucke B, L&#x000fc;tzkendorf S, Karbasiyan M, Bachmann S, Spuler S, Schuelke M. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. <span><span class="ref-journal">PLoS Genet. </span>2010;<span class="ref-vol">6</span>:e1000874.</span> [<a href="/pmc/articles/PMC2837386/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2837386</span></a>] [<a href="/pubmed/20300641" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20300641</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.shastry.2010.2245">Shastry S, Delgado MR, Dirik E, Turkmen M, Agarwal AK, Garg A. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2245–53.</span> [<a href="/pmc/articles/PMC2930069/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2930069</span></a>] [<a href="/pubmed/20684003" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20684003</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.simha.2008.2318">Simha V, Agarwal AK, Aronin PA, Iannaccone ST, Garg A. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2318–26.</span> [<a href="/pmc/articles/PMC2716114/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2716114</span></a>] [<a href="/pubmed/18698612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18698612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.tsoukas.2015.47">Tsoukas MA, Farr MF, Mantzoros CS. Leptin in congenital and HIV-associated lipodystrophy. <span><span class="ref-journal">Metabolism. </span>2015;<span class="ref-vol">64</span>:47–59.</span> [<a href="/pubmed/25267014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25267014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.van_maldergem.2002.722">Van Maldergem L, Magr&#x000e9; J, Khallouf TE, Gedde-Dahl T Jr, Delepine M, Trygstad O, Seemanova E, Stephenson T, Albott CS, Bonnici F, Panz VR, Medina JL, Bogalho P, Huet F, Savasta S, Verloes A, Robert JJ, Loret H, De Kerdanet M, Tubiana-Rufi N, Megarbane A, Maassen J, Polak M, Lacombe D, Kahn CR, Silveira EL, D'Abronzo FH, Grigorescu F, Lathrop M, Capeau J, O'Rahilly S. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:722–33.</span> [<a href="/pmc/articles/PMC1734991/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734991</span></a>] [<a href="/pubmed/12362029" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12362029</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.wee.2014.583">Wee K, Yang W, Sugii S, Han W. Towards a mechanistic understanding of lipodystrophy and seipin function. <span><span class="ref-journal">Biosci Rep. </span>2014;<span class="ref-vol">34</span>:583–91.</span> [<a href="/pmc/articles/PMC4182903/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4182903</span></a>] [<a href="/pubmed/25195639" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25195639</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.wei.2013.478">Wei S, Soh S, Xia SL, Ong WY, Pang ZP, Han W. Seipin regulates excitatory synaptic transmission in cortical neurons. <span><span class="ref-journal">J Neurochem. </span>2013;<span class="ref-vol">124</span>:478–89.</span> [<a href="/pubmed/23173741" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23173741</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bscl.REF.windpassinger.2004.271">Windpassinger C, Auer-Grumbach M, Irobi J, Patel H, Petek E, Horl G, Malli R, Reed JA, Dierick I, Verpoorten N, Warner TT, Proukakis C, Van den Bergh P, Verellen C, Van Maldergem L, Merlini L, De Jonghe P, Timmerman V, Crosby AH, Wagner K. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:271–6.</span> [<a href="/pubmed/14981520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14981520</span></a>]</div></li></ul></div></div><div id="bscl.Chapter_Notes"><h2 id="_bscl_Chapter_Notes_">Chapter Notes</h2><div id="bscl.Author_Notes"><h3>Author Notes</h3><p>Dr Van Maldergem is a teacher of Human Genetics with 25 years' experience in clinical genetics. He is the coordinator of the Berardinelli-Seip study group (created in 1993) and organizer of the first international conference on lipodystrophies (Brussels, 1997).</p></div><div id="bscl.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>8 December 2016 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 June 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 February 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 August 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for BSCL type 1 available on a clinical basis</div></li><li class="half_rhythm"><div>21 December 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 August 2004 (lvm) Revision: Genetically Related Disorders</div></li><li class="half_rhythm"><div>8 September 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>24 April 2003 (lvm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1212</span><span class="label">PMID: <a href="/pubmed/20301391" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301391</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bws/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bvd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1212&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1212/?report=reader">PubReader</a></li><li><a href="/books/NBK1212/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1212" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1212" style="display:none" title="Cite this Page"><div class="bk_tt">Van Maldergem L. Berardinelli-Seip Congenital Lipodystrophy. 2003 Sep 8 [Updated 2016 Dec 8]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1212/pdf/Bookshelf_NBK1212.pdf">PDF version of this page</a> (468K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#bscl.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#bscl.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#bscl.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#bscl.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#bscl.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#bscl.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#bscl.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#bscl.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#bscl.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#bscl.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#bscl.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26580[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BSCL2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10555[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AGPAT2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1492334" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1492334" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1492334" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1492334" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301360" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrin Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrin Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Saheki T, Song YZ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301700" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bennett MJ, Santani AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30358967" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Abetalipoproteinemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Abetalipoproteinemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Burnett JR, Hooper AJ, Hegele RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301448" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hepatic Veno-Occlusive Disease with Immunodeficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hepatic Veno-Occlusive Disease with Immunodeficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Roscioli T, Ziegler JB, Buckley M, Wong M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301391" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301391" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8ca2dde0891169dc1991">Berardinelli-Seip Congenital Lipodystrophy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Berardinelli-Seip Congenital Lipodystrophy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T03:56:02-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88451CDFC83B2100000000043E01F7&amp;ncbi_session=CE88451CDFC8CA11_1086SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1212%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1212&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1212/&amp;ncbi_pagename=Berardinelli-Seip Congenital Lipodystrophy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88451CDFC8CA11_1086SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>